Tirzepatide (Mounjaro, Zepbound) is a long-acting glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist that has previously been approved by the FDA for the treatment of type 2 diabetes and chronic weight management
One small retrospective case series investigated intra-articular BPC-157 injections for knee pain but lacked rigorous methodology, control groups, and long-term follow-up ([6])
Topical cosmetic products are widely available and genuinely effective for skin rejuvenation
Additionally, GSTP1 -transfected HepG2 cells were significantly more resistant against the cytotoxicity of both QIs under GSH-depleted conditions ( Figure 3 )
Surg Today 38:716725 Park J, Hwang S, Yoon I (2017) Advanced growth factor delivery systems in wound management and skin regeneration
December 4, 2024: PCAC reviewed AOD-9604, CJC-1295 (free base, acetate, DAC variants), and thymosin alpha-1